These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 39100671)

  • 1. Advances and clinical challenges of mesenchymal stem cell therapy.
    Mei R; Wan Z; Yang C; Shen X; Wang R; Zhang H; Yang R; Li J; Song Y; Su H
    Front Immunol; 2024; 15():1421854. PubMed ID: 39100671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in mesenchymal stem cell-mediated gene therapy for cancer.
    Dwyer RM; Khan S; Barry FP; O'Brien T; Kerin MJ
    Stem Cell Res Ther; 2010 Aug; 1(3):25. PubMed ID: 20699014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic.
    Wu HH; Zhou Y; Tabata Y; Gao JQ
    J Control Release; 2019 Jan; 294():102-113. PubMed ID: 30553849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects.
    Gil-Chinchilla JI; Zapata AG; Moraleda JM; García-Bernal D
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle.
    Taheri M; Tehrani HA; Dehghani S; Alibolandi M; Arefian E; Ramezani M
    Med Res Rev; 2024 Jul; 44(4):1596-1661. PubMed ID: 38299924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering mesenchymal stem cells for regenerative medicine and drug delivery.
    Park JS; Suryaprakash S; Lao YH; Leong KW
    Methods; 2015 Aug; 84():3-16. PubMed ID: 25770356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.
    Porada CD; Almeida-Porada G
    Adv Drug Deliv Rev; 2010 Sep; 62(12):1156-66. PubMed ID: 20828588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
    Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells-curcumin loaded chitosan nanoparticles hybrid vectors for tumor-tropic therapy.
    Xu M; Asghar S; Dai S; Wang Y; Feng S; Jin L; Shao F; Xiao Y
    Int J Biol Macromol; 2019 Aug; 134():1002-1012. PubMed ID: 31063785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?
    Marofi F; Vahedi G; Hasanzadeh A; Salarinasab S; Arzhanga P; Khademi B; Farshdousti Hagh M
    J Cell Physiol; 2019 Feb; 234(2):1268-1288. PubMed ID: 30191962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing mesenchymal stem cell homing as an anticancer therapy.
    Hagenhoff A; Bruns CJ; Zhao Y; von Lüttichau I; Niess H; Spitzweg C; Nelson PJ
    Expert Opin Biol Ther; 2016 Sep; 16(9):1079-92. PubMed ID: 27270211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy.
    Fan L; Wei A; Gao Z; Mu X
    Biomed Pharmacother; 2023 May; 161():114451. PubMed ID: 36870279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery.
    Wang M; Xin Y; Cao H; Li W; Hua Y; Webster TJ; Zhang C; Tang W; Liu Z
    Biomater Sci; 2021 Feb; 9(4):1088-1103. PubMed ID: 33332490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far.
    Thanuja M Y ; Anupama C ; Ranganath SH
    Adv Drug Deliv Rev; 2018 Jul; 132():57-80. PubMed ID: 29935987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem/stromal cells in cancer therapy.
    Lan T; Luo M; Wei X
    J Hematol Oncol; 2021 Nov; 14(1):195. PubMed ID: 34789315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations.
    Liu Z; Mikrani R; Zubair HM; Taleb A; Naveed M; Baig MMFA; Zhang Q; Li C; Habib M; Cui X; Sembatya KR; Lei H; Zhou X
    Eur J Pharmacol; 2020 Jun; 876():173049. PubMed ID: 32142771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements.
    Su Y; Zhang T; Huang T; Gao J
    Int J Pharm; 2021 May; 600():120477. PubMed ID: 33737099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.
    Moradian Tehrani R; Verdi J; Noureddini M; Salehi R; Salarinia R; Mosalaei M; Simonian M; Alani B; Ghiasi MR; Jaafari MR; Mirzaei HR; Mirzaei H
    J Cell Physiol; 2018 May; 233(5):3831-3845. PubMed ID: 28703313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells Mediated Drug Delivery in Tumor-Targeted Therapy.
    Xie M; Tao L; Zhang Z; Wang W
    Curr Drug Deliv; 2021; 18(7):876-891. PubMed ID: 32819256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.